Devices and methods for effectuating percutaneous shunt procedures

Information

  • Patent Grant
  • 11871928
  • Patent Number
    11,871,928
  • Date Filed
    Tuesday, August 31, 2021
    3 years ago
  • Date Issued
    Tuesday, January 16, 2024
    9 months ago
Abstract
In some implementations, a radially self-expanding endograft prosthesis is provided that includes (i) distal flange that is self-expanding and configured to flip generally perpendicularly with respect to a body of the prosthesis to help seat the prosthesis against a tissue wall, (ii) a distal segment extending proximally from the distal flange that has sufficient stiffness to maintain a puncture open that is formed through a vessel wall (iii) a compliant middle segment extending proximally from the distal segment, the middle segment being more compliant than the distal segment, and having independently movable undulating strut rings attached to a tubular fabric, the combined structure providing flexibility and compliance to allow for full patency while flexed, the segment being configured to accommodate up to a 90 degree bend, (iv) a proximal segment having a plurality of adjacent undulating strut rings that are connected to each other.
Description
FIELD OF THE DISCLOSURE

The present disclosure relates to devices and methods for transcatheter (i.e., performed through the lumen of a catheter) Glenn shunt and Fontan systems (transcatheter cavopulmonary bypass endograft prosthesis and delivery) for nonsurgical, percutaneous extra-anatomic bypass between two adjacent vessels.


BACKGROUND

Children born with single ventricle physiology (SVP), a form of cyanotic congenital heart disease (CCHD), represent 7.7% of all congenital heart disease patients and have a birth incidence of approximately 4-8 per 10,000. In the United States, this represents approximately 2,000 children born each year. Currently, SVP infants undergo a series of staged surgical procedures. The first palliative procedure establishes a balance between systemic and pulmonary output while minimizing the overload on the single ventricle. The following palliative procedure is often cavopulmonary anastomosis through a bidirectional Glenn shunt or hemi-Fontan procedure to allow for passive pulmonary bloodflow. These are surgical procedures that are invasive and traumatic, requiring significant recuperation time and excessive burden on such a young patient.


SUMMARY OF THE DISCLOSURE

The purpose and advantages of the present disclosure will be set forth in and become apparent from the description that follows. Additional advantages of the disclosed embodiments will be realized and attained by the methods and systems particularly pointed out in the written description hereof, as well as from the appended drawings.


A transcatheter approach for obtaining the results of the surgical procedures described above can revolutionize the management of these children with congenital heart disease. As an alternative to the Norwood Procedure, Bi-directional Glenn operation and Fontan procedure, a nonsurgical transcatheter intervention can limit the burden of surgery for infants while also reducing cost. There is a considerable unmet need for a purpose-built cavopulmonary anastomosis device. To Applicant's knowledge no commercial alternatives exist for off-label medical use.


To achieve these and other advantages and in accordance with the purpose of the disclosure, as embodied herein, in one aspect, the disclosure includes embodiments of a cavopulmonary self-expanding implant to permit an interventional cardiologist to create a shunt between the Superior Vena Cava (SVC) and the main pulmonary artery (MPA). The implant can provide an urgently needed option for children with congenital heart failure to avoid the burden of a three-stage surgery (so called palliative surgery), the burden of an additional heart transplantation after failure of the palliative surgeries, or of the lifelong medication intake after direct heart transplantation.


In some implementations, a radially self-expanding endograft prosthesis is provided that includes (i) distal flange that is self-expanding and configured to flip generally perpendicularly with respect to a body of the prosthesis to help seat the prosthesis against a tissue wall, (ii) a distal segment extending proximally from the distal flange that has sufficient stiffness to maintain a puncture open that is formed through a vessel wall (iii) a compliant middle segment extending proximally from the distal segment, the middle segment being more compliant than the distal segment, and having independently movable undulating strut rings attached to a tubular fabric, the combined structure providing flexibility and compliance to allow for full patency while flexed, the segment being configured to accommodate up to a 90 degree bend, (iv) a proximal segment having a plurality of adjacent undulating strut rings that are connected to each other, the proximal segment being sufficiently stiff to seat within and urge against a vessel wall, and (v) a proximal end including a plurality of openings around the proximal end for accommodating a tether that is threaded through the openings to cause the prosthesis to collapse radially inwardly when tension is applied to the tether.


In some implementations, a delivery system is provided including the prosthesis as set forth above, wherein the prosthesis is mounted on a longitudinal inner member and inside of a retractable sheath. Both ends of the tether that is routed through the prosthesis can extend proximally through and out of a proximal region of the delivery system. The delivery system can further include a first set of radiopaque markers near the distal end of the delivery system, and a second set of markers that are visible outside the patient during a procedure that indicates the relative position of the delivery system and prosthesis, wherein the first and second set of markers are maintained in registration with each other during the procedure. The first set of markers can be located on a distal atraumatic tip of the delivery system made of iron oxide to facilitate navigation under MRI or other imaging modality to position the delivery system accurately, and the second set of markers can indicate the relative longitudinal position of the portions of the delivery system. The markers can be configured to indicate when the distal flange of the prosthesis is suitably configured to pull against an inner face of the wall of an artery, such as main pulmonary artery.


The prosthesis can further include a flared or bell-shaped proximal region to enhance apposition against the interior wall of a lumen. The prosthesis can further define at least one fenestration through a sidewall thereof to permit leakage of bodily fluid through the fenestration.


In some implementations, a tubular prosthesis is provided having a first flanged end and a second flanged end, each flanged end being configured to urge against an inner surface of a first body lumen and a second body lumen when the prosthesis is mounted through openings formed into the walls of the first body lumen and second body lumen. The prosthesis can be adjusted in length. The prosthesis can include proximal and distal portions connected by a central elastic region such that the prosthesis can be stretched to cause the flanged ends of the prosthesis to pull against the lumens that the flanged ends are mounted into.


It is to be understood that both the foregoing general description and the following detailed description are exemplary and are intended to provide further explanation of the embodiments disclosed herein.


The accompanying drawings, which are incorporated in and constitute part of this specification, are included to illustrate and provide a further understanding of the method and system of the disclosure. Together with the description, the drawings serve to explain the principles of the disclosed embodiments.





BRIEF DESCRIPTION OF THE DRAWINGS

The foregoing and other objects, aspects, features, and advantages of exemplary embodiments will become more apparent and may be better understood by referring to the following description taken in conjunction with the accompanying drawings, in which:



FIG. 1A depicts a view of a self-expanding prosthesis for performing a Glenn procedure disposed about a distal region of a delivery system for the prosthesis.



FIG. 1B depicts a close-up view of a portion of the prosthesis depicted in FIG. 1A.



FIG. 2A-FIG. 2C illustrate use of the loading tool of FIG. 12 to load a prosthesis such as that of FIG. 1A onto a delivery system.



FIGS. 3A-FIG. 3B illustrate a prosthesis delivery system in its initial deployment position.



FIG. 3C illustrates the prosthesis fully deployed but threaded with a retraction tether.



FIG. 3D illustrates the prosthesis fully deployed with the retraction tether removed.



FIG. 4A illustrates an exemplary prosthesis for a Glenn procedure, for example, in a deployed condition.



FIG. 4B illustrates the same prosthesis being articulated to the right at its distal end.



FIG. 4C illustrates the articulated prosthesis of FIG. 4B to show the flared distal end.



FIG. 4D shows a model of a Glenn shunt prosthesis in accordance with the disclosure being deployed in the main pulmonary artery (MPA) and the superior vena cava (SVC).



FIG. 4E shows a scan of a fully deployed percutaneous cavopulmonary bypass endograft self-expanding prosthesis in a large porcine model used in a Glenn procedure.



FIG. 5A is an isometric schematic view of an illustrative prosthesis for use in a Fontan procedure, and FIG. 5B is a plan view of such a prosthesis.



FIG. 6A is a first illustrative embodiment of a prosthesis for use in a Fontan procedure, and FIG. 6B is a second illustrative embodiment of a prosthesis for use in a Fontan procedure.



FIG. 7 is an image of prostheses deployed in Glenn and Fontan procedures in a test animal in accordance with the disclosure.



FIG. 8A-FIG. 8E are illustrations of various aspects of a method of deploying a prosthesis in accordance with the disclosure.



FIG. 9A-FIG. 9E are illustrations of further aspects of the illustrative prostheses and delivery systems in accordance with the disclosure.



FIG. 10A, B-FIG. 10C, D are illustrations of two further embodiments of prostheses in accordance with the disclosure.



FIGS. 11A-11B are illustrations of a further embodiment of a prosthesis in accordance with the disclosure.



FIGS. 12A-12H are illustrations of a prosthesis loading tool in accordance with the disclosure.





DETAILED DESCRIPTION

Reference will now be made in detail to the present preferred embodiments of the disclosure, examples of which are illustrated in the accompanying drawings. The method and corresponding steps of the disclosed embodiments will be described in conjunction with the detailed description of the system. The exemplary embodiments illustrated herein can be used to perform Glenn and Fontan procedures, but percutaneously. It will be appreciated, however, that the disclosed embodiments, or variations thereof, can be used for a multitude of procedures involving the connection of blood vessels or other biological lumens to native or artificial structures.


Embodiments of a disclosed TCBE (Transcatheter Cavopulmonary Bypass Endograft) represent a potential breakthrough for physicians and young patients who require a safe, less-burdensome, and effective alternative to open heart surgery: a percutaneous approach to heal congenital heart failure.


In particular implementations, the underlying design of the TCBE is based on four components: (i) a distal segment, which is divided into a flange (consisting of a multi-pointed (e.g., six-pointed) star) and two to four rows of connected (e.g., by stitching) undulating wire segments; (ii) a middle segment, which includes longer non-connected undulating wire segments, (iii) and the largest, proximal, segment, which is useful for bridging and stabilization of the implant in the vessel. Depending on the size of the implant, it can be built as a “Glenn Shunt” (about 5 cm in length) or a “Fontan Shunt” (about 8 cm in length). These can be, for example, super elastic Nitinol-supported tubular polyester fabric implants that are delivered through a specially designed delivery system. Preferably, the prosthesis and delivery system are both MRI compatible. The illustrated TCBE embodiments can incorporate several useful features specifically developed for transcatheter cavopulmonary bypass.


For purposes of illustration, and not limitation, as embodied herein and as illustrated in FIG. 1, a prosthesis is provided for transcatheter cavopulmonary bypass situated on a distal region of a delivery system. As can be seen, the device has a tubular stent-like structure formed from ring shaped segments that have an undulating “zig-zag” pattern. A first, proximal end of the prosthesis has an undulating end defined by the proximal-most ring of the prosthesis. The distal end has a similar undulating end formed from a ring of undulating material, but the material is heat treated such that it “flips” from a first direction that is generally parallel to a central longitudinal axis of the prosthesis, and relaxes into a bent over flange having a tip that is generally perpendicular to the longitudinal axis of the prosthesis when permitted to expand. The flange can be oriented at any suitable angle with respect to the longitudinal axis, and is preferably perpendicular thereto, or forms a slightly acute angle with respect to the wall of the prosthesis (e.g., between 70 and 90 degrees). The flange is useful for pulling against the inside of a vessel or other tissue wall when the remaining prosthesis is advanced through an opening in such vessel or other tissue wall, preventing pull through, and permitting a facilitated anastomosis procedure generally, as well as for Glenn and Fontan procedures.


As can be seen, the proximal end of the prosthesis receives a tether therethrough that is routed through the windings of the undulating ring. The tethers are withdrawn proximally through a tubular member (e.g., a sheath) that also passes a core member therethrough that forms the core, or push rod of the delivery system. The core is slidably disposable with respect to the sheath. By advancing the core member with the prosthesis mounted thereto distally outwardly of the sheath, the prosthesis self-expands. However, if the tether is tensioned, it causes the proximal end of the prosthesis to collapse radially inwardly such that the prosthesis can be withdrawn into the sheath. While adjacent undulating rings of the prosthesis particularly near the distal end of the prosthesis can be connected to each other (e.g., by sewing), they can also be kept independent of one another, and be attached to an inner and/or outer tubular fabric layer. The rigidity of the prosthesis is selected and/or configured to provide a desired performance. Thus, the distal end is relatively rigid to maintain an opening in the wall of a vessel or other organ in an open state that the prosthesis traverses through by resisting the force of the vessel wall to want to “close” the hole in itself. The proximal region is less rigid and can accommodate increasing vessel curvature of the vessel that it is mounted in.


The delivery system typically includes an atraumatic distal tip that can pass a guidewire therethrough, and may be provided with one or more radiopaque markers to facilitate visualization under fluoroscopy, for example. The distal end or end region of the sheath of the delivery system (that surrounds the prosthesis when loaded onto the delivery system) can also include a radiopaque marker.



FIGS. 2A-2D illustrate loading of the prosthesis on the core member of the delivery system using a clam shell like loading tool described in further detail below with respect to FIG. 12. FIG. 2C illustrates the delivery system in a collapsed condition. The delivery system includes the aforementioned core member defining a guide wire lumen therethrough. The sheath is fitted over the core, and the tethers run between the components in the annular space between the core and sheath. As shown in FIG. 3A, the flared distal end of the prosthesis flips over from zero to 90 degrees as the sheath is advanced proximally. The proximal end of the prosthesis is held radially inwardly by the tether until tension of the tether is released. Tension can be reapplied to the tether to permit the prosthesis to be fully removable unless the tether is removed.



FIG. 4a shows the disclosed prosthesis for a Glenn procedure. The distal region on the prosthesis is flexible to permit passage of the prosthesis through a curved vessel. FIG. 4D shows the distal flanged end of the prosthesis pulling against the inner wall of the main pulmonary artery (MPA), with the proximal end of the prosthesis extending into the superior vena cava in a Glenn procedure.



FIG. 5A shows a schematic perspective view of a Fontan-type prosthesis, and FIG. 5B shows a side view schematic of such a prosthesis. Adjoining rings of the framework of the prosthesis are attached (e.g., by stitching) to a tubular fabric that preferably passes through the rings of the framework, wherein the framework is made, for example, of 0.014 inch diameter NiTi. The longitudinal dimension of each structural ring can be different. For example, region “A” of the prosthesis can be comparatively stiff, wherein the rings can be attached to each other directly or via the fabric, wherein regions B, C, D, and E can have different, lower stiffnesses.



FIG. 6A illustrates a first embodiment of a prosthesis for a Fontan procedure. The body is similar to that of the prosthesis in FIG. 5, but is made, for example, from 0.013 inch diameter Ni Ti wire. FIG. 6B illustrates a second embodiment that is also formed from the same wire, but the flange is formed at a steeper angle to create an increased flip, or displacement, of the distal flange when the prosthesis is deployed. The prosthesis can include one or more (e.g., 2) fenestrations through the fabric in a central region thereof to permit leakage into the right atrium when the prosthesis spans from its distal end situated within the main pulmonary artery to the superior vena cava.


The star shaped flange on the end of each prosthesis helps the prosthesis seat well within the vasculature. In some embodiments the tethers can be routed through parallel lumens along the length of the delivery system to prevent them from tangling with each other. The prosthesis for the Fontan procedure preferably includes a proximal region that flares out, as illustrated in FIG. 6B to provide enhanced wall apposition.



FIG. 7 illustrates an animal model wherein two prostheses are installed as disclosed herein using the disclosed delivery system; one in a Glenn procedure (connecting the SVC to the MPA to supply blood from the superior vena cava (SVC) to the main pulmonary artery (MPA)), and one in a Fontan procedure (connecting the inferior vena cava (IVC) through the ventricle to the main pulmonary artery (MPA)), wherein the prosthesis includes fenestrations to permit leakage through the prosthesis into the ventricle.



FIG. 8A shows the delivery system with the prosthesis (for the Glenn or Fontan procedure) mounted thereon. FIG. 8B shows the core and distal tip advanced distally, and the distal flared end of the prosthesis deployed. FIG. 8C shows a close up of the flared distal end of the prosthesis. FIG. 8D shows the prosthesis mostly deployed, but the tether tensioned so as to keep the proximal end of the prosthesis held radially inwardly. FIGS. 9A and 9B show two different embodiments of a prosthesis as described above, FIG. 9C shows the prosthesis collapsed and within a sheath of the delivery system, whereas FIG. 9D shows the proximal ends of the delivery systems for each prosthesis. FIG. 9E shows differing sizes of distal tips that can be used, depending on the application. The distal tip acts as a strain relief from a guidewire extending distally outwardly of a central guidewire lumen of the device. As such, while it is preferable to have the tip be relatively long, it is also useful to have it not be too long so as to prevent the delivery system from navigating a relatively narrow lumen when entering it obliquely.



FIGS. 10A-10B show side and isometric views of a prosthesis having a flanged distal end. FIGS. 10CA-10D show side and isometric views of a prosthesis having a flanged distal end as well as a flanged proximal end (upon prosthesis deployment). The illustrated prostheses also include a first section of relatively large diameter, such as near the flanged end, that transitions to a region of lower diameter by way of a transition region. The prosthesis can also be of adjustable telescoping length. The inside diameter preferably remains substantially unchanged when the prosthesis is adjusted in length.



FIGS. 11A-11B show a flanged prosthesis of adjustable length having two flanged ends attached to tubular structural regions that are in turn structurally joined in a central region by an elastic member, such as a spring. A tubular fabric member preferably traverses the inside or the outside of the length of the prosthesis. The prosthesis is shown without such a tubular fabric member for illustrative purposes, and each end can be of a different diameter from the other. Such a prosthesis can be useful, for example, for forming a shunt from the descending aorta to the main pulmonary artery to decompress the aorta. The length can be adjusted of the prosthesis, and tension can be maintained on the prosthesis by way of the spring, helping the flanged ends to seat against the inner walls of the aorta and the MPA.



FIGS. 12A-12H illustrate aspects of a prosthesis loading tool in accordance with the disclosure. As illustrated, the loading tool includes two halves, the inner faces of which are illustrated in FIGS. 12A and 12B. An interior channel including a first funnel portion necking down from a relatively large diameter to a relatively small diameter transitions into a second region of constant diameter, but wherein a step, or shoulder is present on the region of smaller diameter that effectively results in the funnel portion having a slightly smaller diameter than the region of constant diameter. As illustrated in FIGS. 12C-12E, the two halves align and mate with each other by way of a pair of protrusions on one half of the tool being received by a pair of indentations, or holes, on the other half of the tool. In use, the distal end of the sheath that will cover the prosthesis is inserted into the end of the prosthesis having the portion of constant diameter until it abuts the shoulder. In use, the central shaft of the delivery system passes through the sheath and the funnel section. The prosthesis, loaded with the tether on its proximal end, is then advanced into the funnel and is necked down to fit inside the sheath, but surrounding the central shaft, or tubular core member, of the delivery system. Advancing the prosthesis into the funnel section helps effectuate the compression. After the prosthesis is loaded, the loading tool is simply removed.


Generally, during deployment, the delivery system is advanced to a position where the prosthesis should be deployed. The distal tip and core of the guidewire are then advanced distally as well as the prosthesis, and the prosthesis flange is deployed thorough an opening in a wall of a vessel or other tissue wall. The flanged end then urges against the inner wall of the vessel. A corresponding marker can be used on the proximal end of the delivery system to show at what point of relative advancement the flange has been deployed. The delivery system is then pulled proximally slightly to seat the flange. When satisfied with seating, the user holds the inner shaft of the delivery system and pulls back on outer sheath to release the entire implant. The tether can then be de-tensioned to open the proximal end of implant. Finally, the user can pull on one end of the tether to remove it from the implant, and the delivery system can be removed. However, if desired, prior to removal of the tether, the tether can be re-tensioned, causing the proximal end of the prosthesis to collapse radially inwardly, and the prosthesis can be withdrawn into the sheath of the delivery system, and removed.


The devices and methods disclosed herein can be used for other procedures in an as-is condition, or can be modified as needed to suit the particular procedure. In view of the many possible embodiments to which the principles of this disclosure may be applied, it should be recognized that the illustrated embodiments are only preferred examples of the disclosure and should not be taken as limiting the scope of the disclosure.

Claims
  • 1. A method of installing a tubular prosthesis through a sidewall of a native lumenal vessel, comprising: providing a prosthesis having: a distal annular flange configured to help seat the prosthesis when it is pulled proximally;a distal tubular segment extending proximally from the distal flange that has sufficient stiffness to maintain a puncture in an open condition that is formed through a first vessel wall through which the distal segment passes; anda proximal tubular segment that is sufficiently stiff to seat within and urge against a second vessel wall;wherein the prosthesis includes at least one marker that is visible from outside the patient using an imaging modality, wherein the at least one marker of the prosthesis includes radiopaque material or iron oxide;collapsing the prosthesis onto a delivery system, wherein the delivery system includes at least one marker that is visible from outside the patient using the imaging modality, wherein the at least one marker of the delivery system includes radiopaque material or iron oxide;delivering a distal end of the delivery system to an opening defined through a native lumenal vessel wall;deploying the distal annular flange inside of the native lumenal vessel wall; andmaintaining the at least one marker of the prosthesis and the at least one marker of the delivery system in registration with each other during at least a portion of the method.
  • 2. The method of claim 1, further comprising pulling proximally on the delivery system to seat the distal annular flange.
  • 3. The method of claim 2, further comprising deploying the distal tubular segment from the delivery system.
  • 4. The method of claim 3, further comprising deploying the proximal tubular segment from the delivery system.
  • 5. The method of claim 4, wherein the proximal tubular segment is deployed inside of a second lumenal vessel.
  • 6. The method of claim 5, wherein the prosthesis further includes a proximal annular flange coupled to the proximal tubular segment, and further wherein the method further comprises deploying the proximal annular flange inside of the second lumenal vessel against an inner wall of the second lumenal vessel.
  • 7. The method of claim 5, wherein the proximal tubular segment is deployed in a second lumenal vessel and further wherein the proximal tubular segment is urged against an inner wall of the second lumenal vessel.
  • 8. The method of claim 4, further comprising de-tensioning a tether directed through a proximal end of the implant to open the proximal end of the implant.
  • 9. The method of claim 8, further comprising pulling on one end of the tether to remove the tether from the implant.
  • 10. The method of claim 8, further comprising re-tensioning the tether to cause the proximal end of the prosthesis to collapse radially inwardly.
  • 11. The method of claim 10, further comprising withdrawing the prosthesis into a sheath of the delivery system.
  • 12. The method of claim 8, wherein both ends of the tether are directed proximally through and out of a proximal region of the delivery system, and further wherein tension is applied from outside a patient being treated.
  • 13. The method of claim 1, wherein the at least one marker of the prosthesis and the at least one marker of the delivery system are visible under MRI, and further wherein the procedure is conducted while imaging using a MRI imaging modality in real time.
  • 14. The method of claim 1, wherein the prosthesis includes distal markers proximate the distal flange, and further wherein the method includes observing when the distal markers are aligned with the opening in the native lumenal vessel wall.
  • 15. The method of claim 1, wherein the prosthesis further includes a flared or bell-shaped proximal region, and further wherein the method includes deploying the flared or bell shaped proximal region against the interior wall of a lumen.
  • 16. The method of claim 1, wherein the prosthesis further defines at least one fenestration through a sidewall thereof and further wherein the method includes positioning the prosthesis in a manner that permits leakage of bodily fluid through the fenestration.
  • 17. The method of claim 1, wherein the prosthesis can be adjusted in length, and further wherein the method includes adjusting the prosthesis in length when installing the prosthesis.
  • 18. The method of claim 1, wherein the at least one marker of the prosthesis and the at least one marker of the delivery system are visible under fluoroscopy, and further wherein the procedure is conducted while imaging using a fluoroscopic imaging modality in real time.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present patent application is a continuation of and claims the benefit of priority to U.S. patent application Ser. No. 16/399,670, filed Apr. 30, 2019, which is a continuation of and claims the benefit of priority to U.S. patent application Ser. No. 15/267,075, filed Sep. 15, 2016, now U.S. Pat. No. 10,426,482, which in turn claims the benefit of priority to U.S. Provisional Patent Application Ser. No. 62/219,118, filed Sep. 15, 2015, and U.S. Provisional Patent Application Ser. No. 62/363,716, filed Jul. 18, 2016. Each of the foregoing patent applications is incorporated by reference herein for any purpose whatsoever.

US Referenced Citations (153)
Number Name Date Kind
4106129 Carpentier et al. Aug 1978 A
4259753 Liotta et al. Apr 1981 A
4666442 Arru et al. May 1987 A
4692164 Dzemeshkevich et al. Sep 1987 A
5411552 Andersen et al. May 1995 A
5449384 Johnson Sep 1995 A
5606928 Religa et al. Mar 1997 A
5639278 Dereume et al. Jun 1997 A
5749921 Lenker et al. May 1998 A
5788715 Watson, Jr. et al. Aug 1998 A
5861028 Angell Jan 1999 A
5895410 Forber et al. Apr 1999 A
5928281 Huynh et al. Jul 1999 A
6059769 Lunn et al. May 2000 A
6090136 McDonald Jul 2000 A
6106510 Lunn et al. Aug 2000 A
6238430 Klumb et al. May 2001 B1
6375774 Lunn et al. Apr 2002 B1
6599303 Peterson Jul 2003 B1
6602271 Adams et al. Aug 2003 B2
6716231 Rafiee et al. Apr 2004 B1
6733525 Yang et al. May 2004 B2
6790229 Berreklouw Sep 2004 B1
6797000 Simpson et al. Sep 2004 B2
6800081 Parodi Oct 2004 B2
6866677 Douk et al. Mar 2005 B2
6911036 Douk et al. Jun 2005 B2
6926690 Renati Aug 2005 B2
6953476 Shalev Oct 2005 B1
6960217 Bolduc Nov 2005 B2
7044958 Douk et al. May 2006 B2
7066946 Douk et al. Jun 2006 B2
7137993 Acosta Nov 2006 B2
7189259 Simionescu et al. Mar 2007 B2
7195641 Palmaz et al. Mar 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7294135 Stephens et al. Nov 2007 B2
7316706 Bloom et al. Jan 2008 B2
7399315 Iobbi Jul 2008 B2
7425219 Quadri Sep 2008 B2
7442204 Schwammenthal et al. Oct 2008 B2
7442207 Rafiee Oct 2008 B2
7445631 Salahieh et al. Nov 2008 B2
7481838 Carpentier et al. Jan 2009 B2
7491232 Bolduc et al. Feb 2009 B2
7524330 Berreklouw Apr 2009 B2
7655040 Douk et al. Feb 2010 B2
7682352 Rafiee et al. Mar 2010 B2
7699892 Rafiee et al. Apr 2010 B2
7716801 Douk et al. May 2010 B2
7753840 Simionescu et al. Jul 2010 B2
7753949 Lamphere et al. Jul 2010 B2
7780726 Seguin Aug 2010 B2
7799069 Bailey et al. Sep 2010 B2
7806917 Xiao Oct 2010 B2
7806919 Bloom et al. Oct 2010 B2
7815673 Bloom et al. Oct 2010 B2
7947072 Yang et al. May 2011 B2
7955384 Rafiee et al. Jun 2011 B2
7972370 Douk et al. Jul 2011 B2
7998188 Zilla et al. Aug 2011 B2
8002825 Letac et al. Aug 2011 B2
8052750 Tuval et al. Nov 2011 B2
8062355 Figulla et al. Nov 2011 B2
8070802 Lamphere et al. Dec 2011 B2
8092518 Schreck Jan 2012 B2
8092520 Quadri Jan 2012 B2
8092524 Nugent et al. Jan 2012 B2
8226710 Nguyen et al. Jul 2012 B2
8252051 Chau et al. Aug 2012 B2
8308798 Pintor et al. Nov 2012 B2
8337541 Quadri et al. Dec 2012 B2
8348995 Tuval et al. Jan 2013 B2
8348996 Tuval et al. Jan 2013 B2
8353954 Cai et al. Jan 2013 B2
8353955 Styrc et al. Jan 2013 B2
8518096 Nelson Aug 2013 B2
10426482 Rafiee et al. Oct 2019 B2
11179156 Rafiee Nov 2021 B2
20010021872 Bailey et al. Sep 2001 A1
20020032481 Gabbay Mar 2002 A1
20020138138 Yang Sep 2002 A1
20030055495 Pease et al. Mar 2003 A1
20030065386 Weadock Apr 2003 A1
20030097172 Shalev et al. May 2003 A1
20040087998 Lee et al. May 2004 A1
20040127916 Bolduc et al. Jul 2004 A1
20050038508 Gabbay Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050049675 Wallace Mar 2005 A1
20050055082 Ben-Muvhar et al. Mar 2005 A1
20050137769 Salahieh et al. Jun 2005 A1
20050143809 Salahieh et al. Jun 2005 A1
20050177180 Kaganov et al. Aug 2005 A1
20050288706 Widomski et al. Dec 2005 A1
20060085012 Dolan Apr 2006 A1
20060106449 Ben-Muvhar May 2006 A1
20060106450 Ben-Muvhar May 2006 A1
20060173537 Yang et al. Aug 2006 A1
20070043435 Seguin et al. Feb 2007 A1
20070067029 Gabbay Mar 2007 A1
20070250160 Rafiee Oct 2007 A1
20070255398 Yang et al. Nov 2007 A1
20070288089 Gurskis et al. Dec 2007 A1
20070293942 Mizraee Dec 2007 A1
20080015687 Lashinski et al. Jan 2008 A1
20080021537 Ben-Muvhar et al. Jan 2008 A1
20080065191 Bolduc et al. Mar 2008 A1
20080077234 Styrc Mar 2008 A1
20080125860 Webler et al. May 2008 A1
20080208328 Antocci et al. Aug 2008 A1
20080221672 Lamphere et al. Sep 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090062841 Amplatz et al. Mar 2009 A1
20090270966 Douk et al. Oct 2009 A1
20090270976 Douk et al. Oct 2009 A1
20090306768 Quadri Dec 2009 A1
20090319038 Gurskis et al. Dec 2009 A1
20100036479 Hill et al. Feb 2010 A1
20100082094 Quadri et al. Apr 2010 A1
20100100167 Bortlein et al. Apr 2010 A1
20100174363 Castro Jul 2010 A1
20100179648 Richter et al. Jul 2010 A1
20100179649 Richter et al. Jul 2010 A1
20100185275 Richter et al. Jul 2010 A1
20100249923 Alkhatib et al. Sep 2010 A1
20100262232 Annest Oct 2010 A1
20100280606 Naor Nov 2010 A1
20100298931 Quadri et al. Nov 2010 A1
20110112632 Chau et al. May 2011 A1
20110137409 Yang et al. Jun 2011 A1
20110172784 Richter et al. Jul 2011 A1
20110282438 Drews et al. Nov 2011 A1
20110313515 Quadri et al. Dec 2011 A1
20110319988 Schankereli et al. Dec 2011 A1
20110319989 Lane et al. Dec 2011 A1
20120022639 Hacohen Jan 2012 A1
20120059450 Chiang et al. Mar 2012 A1
20120065652 Cully et al. Mar 2012 A1
20120078353 Quadri et al. Mar 2012 A1
20120078360 Rafiee Mar 2012 A1
20120143141 Verkaik Jun 2012 A1
20120179244 Schankereli et al. Jul 2012 A1
20120215303 Quadri et al. Aug 2012 A1
20120316642 Yu et al. Dec 2012 A1
20120323316 Chau et al. Dec 2012 A1
20140018906 Rafiee Jan 2014 A1
20140128965 Rafiee May 2014 A1
20140163668 Rafiee Jun 2014 A1
20140358223 Rafiee et al. Dec 2014 A1
20140039083 Rafiee Feb 2015 A1
20150134051 Donadio et al. May 2015 A1
20190231510 Rafiee et al. Aug 2019 A1
Foreign Referenced Citations (10)
Number Date Country
2412397 Feb 2012 EP
2015519969 Jul 2015 JP
20130110413 Oct 2013 KR
101501614 Mar 2015 KR
100 718 Dec 2010 RU
WO2007121314 Oct 2007 WO
WO2012061809 May 2012 WO
WO2013131069 Sep 2013 WO
WO2015069947 May 2015 WO
WO2015148821 Oct 2015 WO
Non-Patent Literature Citations (11)
Entry
International Search Report dated Jun. 16, 2022 in International Patent Application No. PCT/US2022/018806.
Written Opinion of the International Searching Authority dated May 17, 2022 in International Patent Application No. PCT/US2022/018806.
International Search Report, for related application No. PCT/US2011/059586, dated May 25, 2012.
International Preliminary Report on Patentability and Written Opinion, or related application No. PCT/US2011/059586, dated May 25, 2012.
BioIntegral Surgical, Mitral Valve Restoration System.
International Search Report for co-pending international application No. PCT/US2013/028774, dated Jun. 14, 2013.
International Preliminary Report on Patentability and Written Opinion, on related application No. PCT/US2014/064431 dated Mar. 26, 2015.
International Search Report, for related application No. PCT/US2015/022782, dated Jun. 18, 2015.
International Search Report and Written Opinion in Application No. PCT/US2016/052005, dated Dec. 29, 2016.
International Search Report and Written Opinion in Application No. PCT/US2018/049373, dated Dec. 6, 2018.
Office Action in related Japanese Patent Application No. JP2018-514884 dated Jun. 30, 2020 with English language translation.
Related Publications (1)
Number Date Country
20220125430 A1 Apr 2022 US
Provisional Applications (2)
Number Date Country
62363716 Jul 2016 US
62219118 Sep 2015 US
Continuations (2)
Number Date Country
Parent 16399670 Apr 2019 US
Child 17462190 US
Parent 15267075 Sep 2016 US
Child 16399670 US